Anacor Pharmaceuticals (ANAC)
Create an Alert
4.98
-0.27 -5.14%
NASDAQ
Jun 17, 5:00PM
BATS Real time
Currency in USD
Anacor Pharmaceuticals Shareholders Equity:
4.811M for Dec. 31, 2012Anacor Pharmaceuticals Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 4.811M |
| Sept. 30, 2012 | -6.189M |
| June 30, 2012 | 6.751M |
| March 31, 2012 | 20.68M |
| Dec. 31, 2011 | 13.90M |
| Sept. 30, 2011 | 26.90M |
| June 30, 2011 | 29.74M |
| March 31, 2011 | 43.81M |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
ANAC Shareholders Equity Benchmarks
| Companies | |
|---|---|
| QLT | 372.12M |
| Valeant Pharmaceuticals International | 3.587B |
| Santarus | 107.06M |
ANAC Shareholders Equity Rankings
| Overall |
56th percentile 7370 of 16773 |
| Sector |
54th percentile 646 of 1408 in Healthcare |
| Industry |
54th percentile 207 of 453 in Biotechnology |
ANAC Shareholders Equity Range, Past 5 Years
| Minimum | -103.80M | Jun 2010 |
| Maximum | 56.39M | Dec 2010 |
| Average | -0.7567M |
